The literature is rife with discussion of betalactamase producing enterococci. My question is two fold: 1. How, specifically would betalactamase affect therapy decisions for the organism? 2. Has anyone outside of the original reports seen any? Bob Morrell bmorrell at isnet.is.wfu.edu